Picture of Kobayashi Pharmaceutical logo

4967 — Kobayashi Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
Consumer DefensivesConservativeLarge CapHigh Flyer

Table: Kobayashi Pharmaceutical - 9-MTH group results

Oct 28 (Reuters)- 
             Kobayashi Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Sep 30, 2021        Sep 30, 2020     Dec 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            107.66              105.05           156.00    
                 (+2.5 pct)          (-5.5 pct)       (+3.6 pct)  
  Operating         19.43               19.52            26.00    
                 (-0.5 pct)          (-1.6 pct)       (+0.2 pct)  
  Recurring         21.02               21.04            27.80    
                 (-0.1 pct)          (-1.9 pct)       (+0.3 pct)  
  Net               14.88               15.26            19.50    
                 (-2.5 pct)          (+0.1 pct)       (+1.5 pct)  
  EPS            190.42 yen          195.21 yen       249.48 yen  
  Ann Div                             77.00 yen        81.00 yen  
  -Q2 div         37.00 yen           34.00 yen                   
  -Q4 div                             43.00 yen        44.00 yen  
  
  NOTE - Kobayashi Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T

Recent news on Kobayashi Pharmaceutical

See all news